SCHEMBL7300117

SCHEMBL7300117

CC(C)[C@@H](C=O)NC(=O)CCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC2 Q92769 1/20 0.51
▸ HDAC8 Q9BY41 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ RAB9A P51151 1/20 0.50
▸ CTSB P07858 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ HTT P42858 2/20 0.49
▸ HDAC1 Q13547 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ LMNA P02545 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ CNR2 P34972 1/20 0.48
▸ HDAC3 O15379 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13054604 0.90 SMN1; SMN2 (0.50) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL13054596 0.90 SMN1; SMN2 (0.50) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL16360050 0.87 SMN1; SMN2 (0.55) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL5567744 0.84 POLB (0.56) ALDH1A1MAPTCYP1A2CNR2KDM4E
SCHEMBL19791859 0.84 HDAC2 (0.54) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL6439569 0.84 POLB (0.56) ALDH1A1MAPTCYP1A2CNR2KDM4E
SCHEMBL7294141 0.84 POLB (0.56) ALDH1A1MAPTCYP1A2CNR2KDM4E
SCHEMBL19479628 0.81 MME (0.52) ALDH1A1
SCHEMBL25556928 0.81 HDAC2 (0.58) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A
SCHEMBL7772333 0.80 ALDH1A1 (0.66) HDAC2HDAC8HDAC6SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008228-A COMPRISING A MIXTURE OF CARRIER MONOGLYCERIDES OF MEDIUM CHAIN-FATTY ACIDS HOFFMAN-LA ROCHE INC. (US) 1999-12-28 — — US disclosed
EP-0594540-B1 Antiretroviral acyl compounds CIBA GEIGY AG (CH) 1998-04-01 — — EP disclosed
EP-0831826-A1 PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE F. HOFFMANN-LA ROCHE AG (CH) 1998-04-01 — — EP disclosed
WO-1996039142-A1 PHARMACEUTICAL COMPOSITION COMPRISING A PROTEINASE INHIBITOR AND A MONOGLYCERIDE F. HOFFMANN-LA ROCHE AG (CH) 1996-12-12 — — WO disclosed
EP-0594540-A1 Antiretroviral acyl compounds CIBA-GEIGY AG (CH) 1994-04-27 — — EP disclosed
Send feedback